Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR).


Journal

Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 07 05 2019
revised: 06 06 2019
accepted: 19 06 2019
pubmed: 14 7 2019
medline: 4 9 2019
entrez: 14 7 2019
Statut: ppublish

Résumé

The International Collaboration on Cancer Reporting (ICCR) has developed a suite of detailed datasets for international implementation. These datasets are based on the reporting protocols developed by the Royal College of Pathologists (UK), The Royal College of Pathologists of Australasia and the College of American Pathologists, with modifications undertaken by international expert groups appointed according to ICCR protocols. The dataset for the reporting of renal biopsy for tumour is designed to provide a structured reporting template containing minimum data recording key elements suitable for international use. In formulating the dataset, the ICCR panel incorporated recommendations from the 2012 Vancouver Consensus Conference of the International Society of Urological Pathology (ISUP) and the 2016 edition of the WHO Bluebook on tumours of the urinary and male genital systems. Reporting elements were divided into

Identifiants

pubmed: 31300532
pii: jclinpath-2019-205959
doi: 10.1136/jclinpath-2019-205959
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

573-578

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Brett Delahunt (B)

Department of Pathology and Molecular Medicine, Wellington Sch Med, Wellington, New Zealand brett.delahunt@otago.ac.nz.

John R Srigley (JR)

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Meagan Judge (M)

Royal College of Pathologists of Australasia, Surry Hills, New South Wales, Australia.

Mahul Amin (M)

Department of Pathology and Laboratory medicine, University of Tennessee Health Sciences, Memphis, Tennessee, USA.

Athanase Billis (A)

Department of Anatomic Pathology, Universidade Estadual de Campinas, Campinas, Brazil.

Philippe Camparo (P)

Service d'anatomie et cytologie pathologiques, Hopital Foch, Paris, France.

Stewart Fleming (S)

Department of Cellular and Molecular Pathology, University of Dundee, Dundee, UK.

David Griffiths (D)

Department of Pathology, University Hospital of Wales, Cardiff, UK.

Antonio Lopez-Beltran (A)

Department of Pathology and Surgery, Cordoba University Medical School, /Cordoba, Spain.

Guido Martignoni (G)

Anatomia Patologica, Department of Pathology and Diagnostics, University of Verona, Verona, Italy.

Holger Moch (H)

Department of Pathology, Institute for Surgical Pathology, University Hospital, Zurich, Switzerland.

John N Nacey (JN)

Department of Surgery and Anaesthesia, Wellington Sch Med, Wellington, New Zealand.

Ming Zhou (M)

Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.

Andrew John Evans (AJ)

Department of Pathology, University Health Network, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH